Two Sigma Advisers’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-87,856
| Closed | -$588K | – | 927 |
|
|
2025
Q4 | $588K | Buy |
87,856
+63,540
| +261% | +$377K | ﹤0.01% | 1719 |
|
|
2025
Q3 | $107K | Buy |
24,316
+19,631
| +419% | +$93.1K | ﹤0.01% | 2219 |
|
|
2025
Q2 | $20.8K | Sell |
4,685
-8,871
| -65% | -$37.1K | ﹤0.01% | 2289 |
|
|
2025
Q1 | $76.7K | Buy |
13,556
+10,700
| +375% | +$137K | ﹤0.01% | 2276 |
|
|
2024
Q4 | $60.3K | Sell |
2,856
-1,140
| -29% | -$26.2K | ﹤0.01% | 2270 |
|
|
2024
Q3 | $107K | Sell |
3,996
-3,570
| -47% | -$105K | ﹤0.01% | 2159 |
|
|
2024
Q2 | $216K | Sell |
7,566
-1,250
| -14% | -$43.8K | ﹤0.01% | 2182 |
|
|
2024
Q1 | $374K | Sell |
8,816
-1,710
| -16% | -$76.9K | ﹤0.01% | 1988 |
|
|
2023
Q4 | $563K | Sell |
10,526
-7,980
| -43% | -$360K | ﹤0.01% | 1867 |
|
|
2023
Q3 | $796K | Buy |
18,506
+6,020
| +48% | +$278K | ﹤0.01% | 1615 |
|
|
2023
Q2 | $685K | Buy |
12,486
+3,330
| +36% | +$183K | ﹤0.01% | 1688 |
|
|
2023
Q1 | $385K | Sell |
9,156
-6,120
| -40% | -$182K | ﹤0.01% | 2045 |
|
|
2022
Q4 | $423K | Sell |
15,276
-6,048
| -28% | -$149K | ﹤0.01% | 1946 |
|
|
2022
Q3 | $546K | Buy |
21,324
+5,658
| +36% | +$187K | ﹤0.01% | 1809 |
|
|
2022
Q2 | $564K | Sell |
15,666
-1,030
| -6% | -$46.5K | ﹤0.01% | 1857 |
|
|
2022
Q1 | $1.04M | Sell |
16,696
-8,420
| -34% | -$498K | ﹤0.01% | 1620 |
|
|
2021
Q4 | $1.77M | Sell |
25,116
-4,880
| -16% | -$347K | ﹤0.01% | 1259 |
|
|
2021
Q3 | $2.09M | Sell |
29,996
-230
| -0.8% | -$18.3K | 0.01% | 1226 |
|
|
2021
Q2 | $2.52M | Buy |
30,226
+13,370
| +79% | +$946K | 0.01% | 1186 |
|
|
2021
Q1 | $920K | Buy |
16,856
+2,750
| +19% | +$134K | ﹤0.01% | 1701 |
|
|
2020
Q4 | $605K | Buy |
14,106
+5,140
| +57% | +$192K | ﹤0.01% | 1795 |
|
|
2020
Q3 | $270K | Buy |
8,966
+210
| +2% | +$7.06K | ﹤0.01% | 2055 |
|
|
2020
Q2 | $271K | Sell |
8,756
-180
| -2% | -$4.85K | ﹤0.01% | 2161 |
|
|
2020
Q1 | $197K | Sell |
8,936
-1,320
| -13% | -$35.8K | ﹤0.01% | 2174 |
|
|
2019
Q4 | $313K | Sell |
10,256
-3,130
| -23% | -$90.1K | ﹤0.01% | 2051 |
|
|
2019
Q3 | $412K | Buy |
13,386
+6,620
| +98% | +$165K | ﹤0.01% | 1787 |
|
|
2019
Q2 | $135K | Buy |
6,766
+4,440
| +191% | +$130K | ﹤0.01% | 2185 |
|
|
2019
Q1 | $100K | Sell |
2,326
-20
| -0.9% | -$725 | ﹤0.01% | 2192 |
|
|
2018
Q4 | $75K | Sell |
2,346
-240
| -9% | -$9.46K | ﹤0.01% | 2245 |
|
|
2018
Q3 | $136K | Buy |
2,586
+262
| +11% | +$14.7K | ﹤0.01% | 2131 |
|
|
2018
Q2 | $124K | Sell |
2,324
-92
| -4% | -$4.71K | ﹤0.01% | 2257 |
|
|
2018
Q1 | $121K | Sell |
2,416
-20
| -0.8% | -$897 | ﹤0.01% | 2210 |
|
|
2017
Q4 | $80K | Sell |
2,436
-20
| -0.8% | -$675 | ﹤0.01% | 2169 |
|
|
2017
Q3 | $92K | Sell |
2,456
-50
| -2% | -$1.48K | ﹤0.01% | 2120 |
|
|
2017
Q2 | $64K | Hold |
2,506
| – | – | ﹤0.01% | 2198 |
|
|
2017
Q1 | $65K | Sell |
2,506
-200
| -7% | -$5.76K | ﹤0.01% | 2298 |
|
|
2016
Q4 | $83K | Sell |
2,706
-10
| -0.4% | -$254 | ﹤0.01% | 2278 |
|
|
2016
Q3 | $74K | Sell |
2,716
-330
| -11% | -$9.16K | ﹤0.01% | 2153 |
|
|
2016
Q2 | $87K | Sell |
3,046
-90
| -3% | -$2.86K | ﹤0.01% | 1981 |
|
|
2016
Q1 | $95K | Sell |
3,136
-180
| -5% | -$5.1K | ﹤0.01% | 1944 |
|
|
2015
Q4 | $115K | Buy |
3,316
+1,000
| +43% | +$34.2K | ﹤0.01% | 1756 |
|
|
2015
Q3 | $88K | Buy |
2,316
+120
| +5% | +$5.58K | ﹤0.01% | 1728 |
|
|
2015
Q2 | $125K | Sell |
2,196
-230
| -9% | -$13.1K | ﹤0.01% | 1795 |
|
|
2015
Q1 | $141K | Hold |
2,426
| – | – | ﹤0.01% | 1770 |
|
|
2014
Q4 | $138K | Sell |
2,426
-664
| -21% | -$31.6K | ﹤0.01% | 2287 |
|
|
2014
Q3 | $126K | Sell |
3,090
-640
| -17% | -$29.4K | ﹤0.01% | 2198 |
|
|
2014
Q2 | $170K | Buy |
3,730
+1,650
| +79% | +$69.3K | ﹤0.01% | 2301 |
|
|
2014
Q1 | $98K | Buy |
2,080
+800
| +63% | +$36.4K | ﹤0.01% | 2170 |
|
|
2013
Q4 | $60K | Sell |
1,280
-408
| -24% | -$17.8K | ﹤0.01% | 2236 |
|
|
2013
Q3 | $68K | Buy |
1,688
+263
| +18% | +$10.3K | ﹤0.01% | 2032 |
|
|
2013
Q2 | $51K | Buy |
+1,425
| New | +$54.6K | ﹤0.01% | 2112 |
|
Other funds holding HBIO
WCM
VCM
CCM
MIM
NCNMGF
Two Sigma Advisers's HBIO Position: Q1 2026 in Review
Two Sigma Advisers sold out of Harvard Bioscience (HBIO) in Q1 2026, closing a stake of 87,856 shares — an estimated $588K sold.
Two Sigma Advisers first reported a position in HBIO in Q2 2013 and held it in 51 quarters. The position peaked at $2.52M in Q2 2021. 36 funds tracked by Wall St. Rank hold HBIO as of Q1 2026.
- Two Sigma Advisers reported no remaining Harvard Bioscience position as of Q1 2026 after selling out during the quarter.
- Two Sigma Advisers sold 87,856 Harvard Bioscience shares in Q1 2026, an estimated $588K.
- Two Sigma Advisers first reported a position in Harvard Bioscience in Q2 2013 and held it in 51 quarters.
- Two Sigma Advisers's Harvard Bioscience position peaked at $2.52M in Q2 2021.
- 36 funds tracked by Wall St. Rank held Harvard Bioscience as of Q1 2026.
Based on Two Sigma Advisers's 13F filing for Q1 2026.